UBT251 Injection 4.0 mg (ID 0.5 mg) and UBT251 Injection Placebo

1 treatment and condition followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

UBT251 Injection 4.0 mg (ID 0.5 mg) and UBT251 Injection Placebo
Treatment and conditionWhere it standsTrials
UBT251 Injection 4.0 mg (ID 0.5 mg) and UBT251 Injection Placebo for obesityPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1